• Consensus Rating: Buy
  • Consensus Price Target: $96.30
  • Forecasted Upside: 46.55%
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.04 (1.61%)

This chart shows the closing price for CTLT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Catalent Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTLT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTLT

Analyst Price Target is $96.30
▲ +46.55% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Catalent in the last 3 months. The average price target is $96.30, with a high forecast of $145.00 and a low forecast of $78.00. The average price target represents a 46.55% upside from the last price of $65.71.

This chart shows the closing price for CTLT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 polled investment analysts is to buy stock in Catalent. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2023Deutsche Bank AktiengesellschaftBoost TargetHold$65.00 ➝ $79.00Low
2/9/2023Morgan StanleyBoost TargetOverweight$81.00 ➝ $85.00Low
2/8/2023Royal Bank of CanadaBoost Target$73.00 ➝ $85.00Low
2/8/2023Bank of AmericaBoost Target$60.00 ➝ $78.00Low
2/8/2023Robert W. BairdBoost TargetOutperform$75.00 ➝ $82.00Low
2/8/2023BarclaysBoost TargetOverweight$58.00 ➝ $82.00Low
1/24/2023BarclaysLower TargetOverweight$62.00 ➝ $58.00Low
11/7/2022ArgusDowngradeBuy ➝ HoldLow
11/3/2022Morgan StanleyLower TargetOverweight$120.00 ➝ $81.00Low
11/2/2022Royal Bank of CanadaLower TargetOutperform$125.00 ➝ $73.00Low
11/2/2022BarclaysLower TargetOverweight$105.00 ➝ $62.00Low
11/2/2022Robert W. BairdLower Target$123.00 ➝ $75.00N/A
11/2/2022KeyCorpLower TargetOverweight$125.00 ➝ $85.00Low
11/2/2022Bank of AmericaDowngradeBuy ➝ Neutral$125.00 ➝ $60.00Low
10/6/2022BarclaysLower TargetOverweight$115.00 ➝ $105.00Low
9/6/2022StephensLower Target$145.00Low
8/30/2022Jefferies Financial GroupLower TargetBuy$130.00 ➝ $110.00Low
8/30/2022UBS GroupLower Target$145.00 ➝ $132.00Low
8/30/2022Morgan StanleyLower TargetOverweight$132.00 ➝ $120.00Low
8/30/2022Deutsche Bank AktiengesellschaftLower TargetHold$110.00 ➝ $105.00Low
8/30/2022Royal Bank of CanadaLower TargetOutperform$155.00 ➝ $125.00Low
8/30/2022Bank of AmericaLower TargetBuy$140.00 ➝ $125.00Low
8/30/2022BarclaysLower TargetOverweight$130.00 ➝ $115.00Low
4/12/2022Deutsche Bank AktiengesellschaftLower TargetHold$129.00 ➝ $110.00High
2/2/2022Morgan StanleyLower TargetOverweight$160.00 ➝ $145.00Low
1/27/2022BarclaysLower TargetOverweight$160.00 ➝ $130.00Low
12/16/2021BarclaysInitiated CoverageOverweight$160.00Low
11/3/2021Morgan StanleyBoost TargetOverweight$147.00 ➝ $160.00Low
11/3/2021Royal Bank of CanadaBoost TargetOutperform$145.00 ➝ $155.00Low
9/8/2021Deutsche Bank AktiengesellschaftBoost TargetHold$123.00 ➝ $162.00Medium
8/31/2021UBS GroupBoost TargetBuy$138.00 ➝ $145.00Low
8/31/2021KeyCorpBoost TargetOverweight$142.00 ➝ $155.00Low
8/31/2021Bank of AmericaBoost TargetBuy$140.00 ➝ $160.00Low
8/31/2021Morgan StanleyBoost TargetOverweight$135.00 ➝ $147.00Low
8/31/2021Royal Bank of CanadaBoost TargetOutperform$137.00 ➝ $145.00Low
3/2/2021ArgusBoost TargetBuy$130.00 ➝ $140.00Medium
2/3/2021Morgan StanleyBoost TargetOverweight$115.00 ➝ $135.00High
2/3/2021UBS GroupBoost TargetBuy$115.00 ➝ $135.00High
2/3/2021Royal Bank of CanadaBoost TargetOutperform$125.00 ➝ $137.00High
1/8/2021JPMorgan Chase & Co.Boost TargetOverweight$110.00 ➝ $130.00Low
11/5/2020Deutsche Bank AktiengesellschaftBoost TargetHold$91.00 ➝ $100.00Low
11/4/2020Robert W. BairdBoost TargetOutperform$100.00 ➝ $109.00High
11/4/2020Jefferies Financial GroupBoost TargetBuy$107.00 ➝ $115.00High
11/4/2020UBS GroupBoost TargetBuy$105.00 ➝ $115.00High
11/4/2020Royal Bank of CanadaBoost TargetOutperform$98.00 ➝ $105.00High
11/4/2020Morgan StanleyBoost TargetOverweight$98.00 ➝ $115.00High
9/24/2020ArgusBoost Target$100.00 ➝ $110.00Low
9/4/2020Deutsche Bank AktiengesellschaftBoost TargetIn-Line ➝ Hold$62.00 ➝ $91.00Low
9/1/2020Royal Bank of CanadaBoost Target$94.00 ➝ $98.00Low
9/1/2020Morgan StanleyBoost TargetOverweight$95.00 ➝ $98.00High
9/1/2020Robert W. BairdBoost TargetPositive ➝ Outperform$90.00 ➝ $100.00High
8/11/2020Jefferies Financial GroupReiterated RatingBuy$105.00High
7/31/2020Morgan StanleyBoost TargetOverweight$75.00 ➝ $95.00Low
7/21/2020UBS GroupBoost TargetBuy$77.00 ➝ $97.00Low
7/14/2020Royal Bank of CanadaBoost TargetPositive ➝ Outperform$78.00 ➝ $86.00Medium
6/26/2020Robert W. BairdBoost TargetOutperform$74.00 ➝ $80.00Medium
6/25/2020ArgusInitiated CoverageBuyMedium
5/6/2020Robert W. BairdBoost TargetOutperform$63.00 ➝ $74.00Low
5/6/2020Morgan StanleyBoost TargetOverweight$57.00 ➝ $75.00Low
5/6/2020UBS GroupBoost TargetBuy$70.00 ➝ $77.00Low
5/6/2020Deutsche Bank AktiengesellschaftBoost TargetHold$59.00 ➝ $62.00High
4/20/2020Royal Bank of CanadaInitiated CoverageOutperform$65.00High
4/13/2020Robert W. BairdLower TargetOutperform$67.00 ➝ $63.00Low
3/27/2020Morgan StanleyLower TargetOverweight$67.00 ➝ $57.00High
3/2/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$59.00High
2/4/2020Robert W. BairdReiterated RatingOutperform$60.00 ➝ $67.00High
2/4/2020Morgan StanleyBoost TargetOverweight$64.00 ➝ $67.00Medium
1/27/2020StephensBoost TargetOverweight$65.00 ➝ $75.00Low
10/17/2019StephensInitiated CoverageOverweight$56.00High
8/28/2019Robert W. BairdBoost TargetOutperform$50.00 ➝ $60.00Low
8/28/2019Morgan StanleyBoost TargetOverweight$50.00 ➝ $61.00Low
7/23/2019UBS GroupBoost TargetBuy$64.00Low
6/21/2019Jefferies Financial GroupUpgradeHold ➝ Buy$50.00 ➝ $62.00High
4/16/2019Morgan StanleyBoost TargetOverweight$46.00 ➝ $50.00High
4/16/2019Jefferies Financial GroupBoost TargetHold$44.00 ➝ $50.00High
4/16/2019UBS GroupUpgradeNeutral ➝ Buy$43.00 ➝ $54.00High
3/5/2019First AnalysisReiterated RatingOutperform$49.00Low
12/3/2018Morgan StanleySet TargetBuy$46.00Low
11/16/2018Royal Bank of CanadaSet TargetBuy$45.00Low
11/15/2018Robert W. BairdInitiated CoverageOutperformLow
11/7/2018Royal Bank of CanadaSet TargetBuy$44.00Medium
11/7/2018First AnalysisUpgradeNeutral ➝ Outperform$47.00 ➝ $43.00High
10/9/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$48.00Low
8/29/2018JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$50.00 ➝ $55.00Medium
(Data available from 4/1/2018 forward)

News Sentiment Rating

0.63 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 39 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
  • 4 very positive mentions
  • 32 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 5 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
  • 4 very positive mentions
  • 24 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
  • 9 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 15 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 19 very positive mentions
  • 29 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
  • 10 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 2 very negative mentions

Current Sentiment

  • 10 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 2 very negative mentions

Recent Stories by Sentiment

Catalent logo
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment is composed of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is involved in packaging, storage, distribution, and inventory manag
Read More

Today's Range

Now: $65.71
Low: $64.51
High: $66.00

50 Day Range

MA: $65.55
Low: $49.57
High: $74.26

52 Week Range

Now: $65.71
Low: $40.69
High: $115.33


1,069,895 shs

Average Volume

1,793,130 shs

Market Capitalization

$11.83 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Catalent?

The following Wall Street analysts have issued reports on Catalent in the last year: Argus, Bank of America Co., Barclays PLC, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., KeyCorp, Morgan Stanley, Robert W. Baird, Royal Bank of Canada, Stephens, StockNews.com, TheStreet, and UBS Group AG.
View the latest analyst ratings for CTLT.

What is the current price target for Catalent?

10 Wall Street analysts have set twelve-month price targets for Catalent in the last year. Their average twelve-month price target is $96.30, suggesting a possible upside of 46.6%. Stephens has the highest price target set, predicting CTLT will reach $145.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $78.00 for Catalent in the next year.
View the latest price targets for CTLT.

What is the current consensus analyst rating for Catalent?

Catalent currently has 3 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CTLT will outperform the market and that investors should add to their positions of Catalent.
View the latest ratings for CTLT.

What other companies compete with Catalent?

How do I contact Catalent's investor relations team?

Catalent's physical mailing address is 14 SCHOOLHOUSE ROAD, SOMERSET NJ, 08873. The company's listed phone number is (732) 537-6200 and its investor relations email address is [email protected] The official website for Catalent is www.catalent.com. Learn More about contacing Catalent investor relations.